Eliglustat Tartrate

Overview

Eliglustat Tartrate is a glucosylceramide synthase inhibitor used for the long-term treatment of adult patients with Gaucher disease type 1. It works by reducing the amount of glucosylceramide that the body produces, helping to manage the condition.

API suppliers (1)

Suppliers of Eliglustat Tartrate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TIANISH LABORATORIES PRIVATE LTD1 active DMF

Therapeutic areas